AzTrials
AzTrials

Traumatic Brain Injury With Prolonged Loss of ConsciousnessNCT04306601

Low-Intensity Focused Ultrasound on Individuals With Disorder of Consciousness of Traumatic Brain Injury

A study testing Low-Intensity Focused Ultrasound in people with Traumatic Brain Injury With Prolonged Loss of Consciousness, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low-intensity focused ultrasound can be effective in severe TBI patients with disorder of consciousness. This study is a prospective single arm, open-label and explorative clinical trial to evaluate the therapeutic effect of recovery from DoC and safety of low-intensity focused ultrasound stimulation at thalamic area… Read more about this study

Who is it for?
Ages 19 years and older
What is being tested?
Low-Intensity Focused Ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteSouth Korea
Study dates
25 Jun 2020to 22 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age is 19 years or higher
  • The patient was diagnosed with traumatic brain injury
  • A patient 6 months after brain damage
  • A patient was diagnosed with unwakefulness syndrome or minimally conscious state

Who cannot join

  • The patient needs changes of drugs that can affect changes in consciousness during the study's participation.
  • The drugs listed below are not allowed to be used in combination, unless they are being taken stably from 4 weeks prior to screening.
  • Benzodiazepines
  • Anti-epileptic drugs
  • Selective serotonin reuptake inhibitor
  • Opioids
Show all 13Show fewer
  • Cardiopulmonary resuscitation was performed on the patient for more than 10 minutes
  • The patients has uncontrolled seizure.
  • The patient has severe thalamic atrophy of both sides, and it is impossible to determine the target area to be stimulated by sonication
  • The patient has severe medical conditions which can affect the consciousness
  • In brain computed tomography, calcification or foreign object (metallic materials, shunt catheter, etc.) that affects sonication are found in brain or skull.
  • In brain MRI, an abnormal brain blood flow or blood vessel is found
  • The patient is pregnant

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Hospital

    Seoul, 110-744

Other trials in South Korea

About this study

Official title: A Prospective, Open-Label, Single-Arm, Single-Center, Explorative Clinical Trial to Assess the Effect and Safety of Low-Intensity Focused Ultrasound on Individuals With Disorder of Consciousness After Traumatic Brain Injury

Low-intensity focused ultrasound can be effective in severe TBI patients with disorder of consciousness. This study is a prospective single arm, open-label and explorative clinical trial to evaluate the therapeutic effect of recovery from DoC and safety of low-intensity focused ultrasound stimulation at thalamic area in patients with post-traumatic DoC.

Read the detailed description

Traumatic brain injury (TBI) is an important global health concern. It is estimated that about 70 million individuals will suffer a traumatic brain injury (TBI) each year. Serious TBIs for hospitalization or death is at least 10 million annually.

Recently, advances in neurocritical care have led to an increase in the number of severe TBI patients recovering cognitive and physical function, eventually returning to independent life. However, some of severe TBI patients fail to fully recover consciousness. This condition is called disorder of consciousness (DoC). They recover from coma and maintain sleep-wake cycle, but have impaired awareness of themselves and their environment. These states are called unresponsive wakefulness syndrome or minimally conscious state. These conditions make patients loss all autonomy and heavy emotional and financial burden on their families. In addition to these devastating effects, these conditions are known to increase burn out rates in caregivers.

In the past, patients with post-traumatic DoC were considered to be "nothing to do". However, treatments such as sensory stimulation, physiotherapy, and medication have been used and studied recently. Sensory stimulation is based on the idea that enriched stimulations benefit neural plasticity and recovery. Most studies of sensory stimulation have been case-reports, with few randomized controlled study. Physiotherapy mainly includes range of motion, posture changes, and so on. Almost all hospitals offer physiotherapy, but there is still insufficient evidence to conclude that it is effective for patients with post-traumatic DoC. Studies on pharmacologic treatments in patients with DoC are mainly related to dopaminergics, because dopaminergics can stimulate the reticular activating system to improve wakefulness and attention. Among them, amantadine is proved to be an effective treatment through a large randomized controlled clinical trial in patients with post-traumatic DoC. However, although amantadine is effective in accelerating the pace of recovery, there is a limitation that the effect on long-term outcomes remains unknown.

As a scientific understanding of the consciousness grows, many studies have been conducted to restore the consciousness by neuromodulation techniques, such as median nerve stimulation, dorsal column stimulation, transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS) and deep brain stimulation (DBS). Median nerve stimulation was attempted to direct sensory stimulation to the brain. However, it has been shown to be ineffective in small randomized controlled study. Attempts to stimulate the dorsal column of spinal cord directly have been made. However, because it is invasive procedure, no randomized controlled studies have been performed.

Over the past 10 years, as a restorative treatment of consciousness after TBI, the neurostimulation such as tDCS, rTMS and DBS has received increased attention. In a double-blind sham-controlled crossover design study, Thibaut et al. have investigated the efficacy of tDCS in 55 DOC patients. Significant behavioral changes were observed after tDCS in MCS patients, but after 1 year, the effect was not maintained. DBS has been generally used in Parkinson's disease, but it has been also performed in patients with DoC because it can directly stimulate thalamus. Improved the consciousness after DBS have been reported , but the evidence isn't still sufficient and the risk is too high to be administered to patients with post-traumatic DoC.

Low-intensity focused ultrasound (LIFU) has been newly proposed as a technique to overcome the limitations of existing neurostimulation techniques. LIFU has a spatial resolution of only 2-5 mm and a depth of penetration of more than 10-15 cm. Thus, it can pass through the skull to stimulate the deep brain tissue and can also stimulate finely.

In recent years, we have focused on studies of stimulating nerve tissue using a focused ultrasound stimulation system. It was reported that activation and inhibition control of motor and visual nervous system in rabbits can be achieved using a focused ultrasound stimulation system. We also reported that the thalamus of anesthetized rats was stimulated with a focused ultrasound stimulation system, resulting in a shorter recovery time from anesthesia. The image-guided navigation system using MRI made it possible to focus the ultrasound stimulation at the target point of the brain with high accuracy. In 2018, a wearable FUS headgear for a rat model was developed and the effect of long- term changes of brain function by focused ultrasound stimulation was reported, thereby identifying the possibility of neuroplasticity using LIFU.

In 2016, Monti et al. reported a clinical case of recovery of consciousness in a traffic accident patient who had been in a coma for about 20 days. The central thalamic area of the patient was stimulated with LIFU for 5-10 minutes each day, restoring consciousness from the 3rd day and starting walking on the 5th day. This result is supported by the relationship between central thalamus and consciousness. In addition, it is similar to the case that central thalamus stimulation using DBS in the patient who had MCS for 6 years after TBI modulated behavioral responses of the patient.

Based on above results, this study's aim is to evaluate the therapeutic effect of recovery from DoC and safety of LIFU stimulation at thalamic area in patients with post-traumatic DoC.

Being tested
Low-Intensity Focused Ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-Intensity Focused UltrasoundDevice

    Low-intensity focused ultrasound brain stimulation using focused ultrasound system (NS-US100; NEUROSONA Co. Ltd., Seoul, Korea)

Study groups in NCT04306601
Study groupRoleWhat they receive
Low-Intensity focused ultrasound brain stimulationExperimentalLow-intensity focused ultrasound brain stimulation using focused ultrasound system (NS-US100; NEUROSONA Co. Ltd., Seoul, Korea)
Receives: Device: Low-Intensity Focused Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical evaluation

    Coma Recovery scale - Revised

    The CRS consists of 25 hierarchically arranged items that comprise 6 subscales addressing auditory, visual, motor, oromotor, communication, and arousal processes. Scoring is based on the presence or absence of specific behavioral responses to sensory stimuli administered in a standardized manner. The lowest item on each subscale represents reflexive activity, whereas the highest items represent cognitively mediated behaviors.

    The total minimum and maximum values are 0 and 23.

    Measured: 6 weeks

  2. Quantitative electroencephalography

    Weighted phase lag index

    Measured: 2 weeks

  3. Resting state functional MRI

    ALFF (amplitude of low-frequency fluctuation)

    Measured: 2 weeks

Secondary outcomes (4)
  1. Adverse reaction

    Seizure event, Electroencephalography

    Measured: 2 weeks

  2. Rancho Los Amigos Levels of Cognitive Functioning Scale (LOCF)

    Clinical evaluation of cognitive and behavioral patterns of traumatic brain injury patients

    After being assessed based on the LOCF, individuals with brain injury receive a score from one to eight. A score of one represents non-responsive cognitive functioning, whereas a score of eight represents purposeful and appropriate functioning.

    Measured: 6 weeks

  3. Glasgow Coma Scale

    Clinical evaluation of impairment of consciousness

    A person is assessed against the criteria of this scale, and the resulting points give a person's score between 3 (indicating deep unconsciousness) and either 14 (original scale) or 15 (more widely used, modified or revised scale).

    Measured: 6 weeks

  4. Glasgow Outcome Scale Extended

    The Glasgow Outcome Scale (GOS) is a global scale for functional outcome that rates patient status into one of eight categories.

    (Death, Vegetative state, Lower severe disability, Upper severe disability, Lower moderate disability, Upper moderate disability, Lower good recovery, Upper good recovery)

    The higher scores mean a better outcome.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2020
  2. Study start25 Jun 2020
  3. Primary completion28 Nov 2022
  4. Study completion22 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Patients with unwakefulness syndrome or minimally conscious state after traumatic brain injury
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04306601
Sponsor's protocol ID
TBI_DoC_tFUS
Status last verified
Apr 2024
First submitted
8 Mar 2020
Last updated
17 Apr 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data can be shared on reasonable request

Questions about this trial

What is this clinical trial studying?

A study testing Low-Intensity Focused Ultrasound in people with Traumatic Brain Injury With Prolonged Loss of Consciousness, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical evaluation (time frame: 6 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in